Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
64.87 USD | +0.14% | -1.35% | -19.70% |
May. 02 | UBS Adjusts Price Target on Gilead Sciences to $70 From $75, Maintains Neutral Rating | MT |
May. 01 | Deutsche Bank Adjusts Price Target on Gilead Sciences to $73 From $75 | MT |
- Stock Market
- Equities
- GILD Stock
- News Gilead Sciences, Inc.